Publicaciones (57) Publicaciones de José Ignacio Monreal Marquiegui

2024

  1. Evaluation of measured and calculated small dense low-density lipoprotein in capillary blood and association with the metabolic syndrome

    Clinica Chimica Acta, Vol. 557

2023

  1. Isoliquiritigenin in combination with visceral adipose tissue and related markers as a predictive tool for nonalcoholic fatty liver disease

    Journal of Physiology and Biochemistry

2022

  1. A nutrigenetic tool for precision dietary management of non-alcoholic fatty liver disease deeming insulin resistance markers

    Panminerva medica, Vol. 64, Núm. 4, pp. 485-496

  2. Neck Circumference for NAFLD Assessment during a 2-Year Nutritional Intervention: The FLiO Study

    Nutrients, Vol. 14, Núm. 23

2021

  1. Three different genetic risk scores based on fatty liver index, magnetic resonance imaging and lipidomic for a nutrigenetic personalized management of nafld: The fatty liver in obesity study

    Diagnostics, Vol. 11, Núm. 6

2019

  1. GLP-1 limits adipocyte inflammation and its low circulating pre-operative concentrations predict worse type 2 diabetes remission after bariatric surgery in obese patients

    Journal of Clinical Medicine, Vol. 8, Núm. 4

  2. Manual de bioquímica para enfermería

    , 2019

  3. Trabecular bone score and bone remodelling markers identify perimenopausal women at high risk of bone loss

    Clinical Endocrinology, Vol. 91, Núm. 3, pp. 391-399

2017

  1. The Role and Potential Therapeutic Implications of the Fibroblast Growth Factors in Energy Balance and Type 2 Diabetes

    Current Diabetes Reports, Vol. 17, Núm. 6

2016

  1. Long-term metabolic correction of Wilson's disease in a murine model by gene therapy

    Journal of Hepatology, Vol. 64, Núm. 2, pp. 419-426

2013

  1. Changes in male rat urinary protein profile during puberty: A pilot study

    BMC Research Notes, Vol. 6, Núm. 1

  2. Erratum: Traditional and novel bone remodeling markers in premenopausal and postmenopausal women (Journal of Clinical Endocrinology and Metabolism (2013) 98 (E1740-E1748) DOI:10.1210/jc.2013-2264)

    Journal of Clinical Endocrinology and Metabolism

  3. Traditional and novel bone remodeling markers in premenopausal and postmenopausal women

    Journal of Clinical Endocrinology and Metabolism, Vol. 98, Núm. 11

2011

  1. Investigación entre pacientes y análisis

    Revista del laboratorio clínico, Vol. 4, Núm. 1, pp. 1-2

  2. Utilización nutritiva de β-carotenos

    Fundamentos de nutrición y dietética: bases metodológicas y aplicaciones (Editorial Médica Panamericana), pp. 199-201

2009

  1. Enhanced actions of insulin-like growth factor-I and interferon-α co-administration in experimental cirrhosis

    Liver International, Vol. 29, Núm. 1, pp. 37-46

2007

  1. Cómo saber interpretar la bioquímica clínica

    Pamplona : J.I. Monreal, 2007

  2. Polymorphisms in the thymidylate synthase and dihydropyrimidine dehydrogenase genes predict response and toxicity to capecitabine-raltitrexed in colorectal cancer

    Oncology Reports, Vol. 17, Núm. 2, pp. 325-328

2003

  1. Entre el análisis y la historia clínica: guiones de bioquímica clínica

    Pamplona? : Monreal, 2003

  2. Independent association of fibrinogen with carotid intima-media thickness in asymptomatic subjects

    Cerebrovascular Diseases, Vol. 16, Núm. 4, pp. 356-362